Fiona Hamilton Marshall
Corporate Officer/Principal bij MERCK & CO., INC.
Vermogen: 485 982 $ op 31-03-2024
Profiel
Fiona Hamilton Marshall was the founder of Heptares Therapeutics Ltd.
founded in 2007, where she held the title of Director & Chief Scientific Officer.
Currently, she is Senior VP & Global Head-Discovery Sciences at Merck & Co., Inc. and President at Novartis Institutes for Biomedical Research, Inc. starting in 2022.
In her former positions, she was Chairman at G7 Therapeutics AG, Director-Discovery Pharmacology at Millennium Pharmaceuticals, Inc., Director at CellAura Technologies Ltd., Head-Molecular Pharmacology Department at Glaxo Wellcome Plc, Chief Scientific Officer & Executive VP at Sosei Group Corp., Council Member at Academy of Medical Sciences, and Member at Biotechnology & Biological Sciences Research Council.
Dr. Marshall received her undergraduate degree from the University of Bath and her doctorate from the University of Cambridge.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVARTIS AG
0.00% | 31-12-2023 | 5 010 ( 0.00% ) | 485 982 $ | 31-03-2024 |
Actieve functies van Fiona Hamilton Marshall
| Bedrijven | Functie | Begin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | President | 01-11-2022 |
Eerdere bekende functies van Fiona Hamilton Marshall
| Bedrijven | Functie | Einde |
|---|---|---|
| NXERA PHARMA CO., LTD. | Chief Tech/Sci/R&D Officer | 28-02-2018 |
Academy of Medical Sciences
 Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Director/Board Member | - |
G7 Therapeutics AG
 G7 Therapeutics AG Pharmaceuticals: MajorHealth Technology G7 Therapeutics AG develops GPCRs for the design of novel medicine. It plays a central role in cellular responses to a diverse array of signals including neurotransmitters, hormones and metabolites, giving this class of proteins enormous pharmacological relevance. The company was founded by Lutz Kummer and Jörn Aldag and is headquartered in Schlieren, Switzerland. | Chairman | - |
CellAura Technologies Ltd.
 CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Director/Board Member | - |
Biotechnology & Biological Sciences Research Council
 Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Fiona Hamilton Marshall
| University of Bath | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| NXERA PHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
Academy of Medical Sciences
Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Commercial Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Biotechnology & Biological Sciences Research Council
Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom. | Commercial Services |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
CellAura Technologies Ltd.
CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
G7 Therapeutics AG
G7 Therapeutics AG Pharmaceuticals: MajorHealth Technology G7 Therapeutics AG develops GPCRs for the design of novel medicine. It plays a central role in cellular responses to a diverse array of signals including neurotransmitters, hormones and metabolites, giving this class of proteins enormous pharmacological relevance. The company was founded by Lutz Kummer and Jörn Aldag and is headquartered in Schlieren, Switzerland. | Health Technology |
